Etaracizumab
http://dbpedia.org/resource/Etaracizumab an entity of type: Thing
إيتاراسيزوماب هو جسم مضاد وحيد النسيلة مأنسن يستخدم في علاج الأورام الميلانينية النقيلة وسرطان الموثة وسرطان المبيض وأنواع أخرى من السرطان. تصنعه .
rdf:langString
Etaracizumab, also known as MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune. It is an enhanced iteration of Vitaxin, also known as MEDI-523. Both are derived from the mouse antibody LM609.
rdf:langString
L'etaracizumab o etaratuzumab o MEDI-522, nome commerciale Abegrin, è un anticorpo monoclonale umanizzato, studiato per il trattamento del melanoma metastatico e del carcinoma della prostata, del tumore dell'ovaio ed altri tipi di tumore. Il farmaco è sviluppato dalla . Il target molecolare del farmaco è l'antigene: integrina alfa-v beta-3.
rdf:langString
rdf:langString
إيتاراسيزوماب
rdf:langString
Etaracizumab
rdf:langString
Etaracizumab
xsd:integer
12233187
xsd:integer
1050073723
rdf:langString
none
xsd:integer
6392
xsd:integer
892553
rdf:langString
none
xsd:integer
9908
rdf:langString
D09342
xsd:integer
1732
xsd:integer
1996
xsd:integer
42
rdf:langString
zu/o
rdf:langString
alpha-v beta-3 integrin
rdf:langString
Abegrin
rdf:langString
mab
xsd:integer
41
rdf:langString
changed
xsd:integer
457121095
rdf:langString
changed
rdf:langString
إيتاراسيزوماب هو جسم مضاد وحيد النسيلة مأنسن يستخدم في علاج الأورام الميلانينية النقيلة وسرطان الموثة وسرطان المبيض وأنواع أخرى من السرطان. تصنعه .
rdf:langString
Etaracizumab, also known as MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune. It is an enhanced iteration of Vitaxin, also known as MEDI-523. Both are derived from the mouse antibody LM609.
rdf:langString
L'etaracizumab o etaratuzumab o MEDI-522, nome commerciale Abegrin, è un anticorpo monoclonale umanizzato, studiato per il trattamento del melanoma metastatico e del carcinoma della prostata, del tumore dell'ovaio ed altri tipi di tumore. Il farmaco è sviluppato dalla . Il target molecolare del farmaco è l'antigene: integrina alfa-v beta-3.
rdf:langString
mab
xsd:nonNegativeInteger
3524
rdf:langString
Abegrin
xsd:string
892553-42-3
xsd:string
41W9MFI160
xsd:string
D09342